Unfortunately, loss or reduction of PTEN protein is common in numerous tumors, including breast cancer (Perren et al., 1999; Costa et al., 2020), and PTEN is thought to be a necessary factor for MLN4924 sensitivity. Here, PTEN is linked to breast cancer.